- We will send in 10–14 business days.
/images/books/14521268/9786207028351.jpg)
- Author: Ourida Gacem Benelmouffok
- Publisher: Our Knowledge Publishing
- ISBN-10: 620702835X
- ISBN-13: 9786207028351
- Format: 15.2 x 22.9 x 0.8 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Systemic lupus erythematosus in children (e-book) (used book) | bookbook.eu
Reviews
Description
Systemic lupus erythematosus in children is a chronic, systemic and autoimmune disease whose diagnosis is not always easy. Its clinical expression is heterogeneous with sometimes atypical manifestations contributing to diagnostic error. This entity is distinguished by severe damage, notably renal, neurological and hematological damage, the outcome of which can be serious. These individualizations pose a real diagnostic challenge. The lack of pediatric studies regarding treatment makes targeted and adequate care difficult. It is most often based on a heavy therapeutic arsenal in a growing being. The use of these medications with a good benefit/risk balance could avoid considerable comorbidity. Hydroxychloroquine is experiencing renewed interest, after having proven its beneficial effects; its therapeutic and preventive properties on relapses and control of lupus disease. The progression can be marked by uncontrolled attacks which can compromise the vital prognosis. Complications may concern the organs initially affected or other visceral damage.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 16d.20:58:53
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Ourida Gacem Benelmouffok
- Publisher: Our Knowledge Publishing
- ISBN-10: 620702835X
- ISBN-13: 9786207028351
- Format: 15.2 x 22.9 x 0.8 cm, softcover
- Language: English English
Systemic lupus erythematosus in children is a chronic, systemic and autoimmune disease whose diagnosis is not always easy. Its clinical expression is heterogeneous with sometimes atypical manifestations contributing to diagnostic error. This entity is distinguished by severe damage, notably renal, neurological and hematological damage, the outcome of which can be serious. These individualizations pose a real diagnostic challenge. The lack of pediatric studies regarding treatment makes targeted and adequate care difficult. It is most often based on a heavy therapeutic arsenal in a growing being. The use of these medications with a good benefit/risk balance could avoid considerable comorbidity. Hydroxychloroquine is experiencing renewed interest, after having proven its beneficial effects; its therapeutic and preventive properties on relapses and control of lupus disease. The progression can be marked by uncontrolled attacks which can compromise the vital prognosis. Complications may concern the organs initially affected or other visceral damage.
Reviews